• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Survivin 一览。

Survivin at a glance.

机构信息

Department of Biochemistry, School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, UK

The Wistar Institute Cancer Center, Philadelphia, PA 19104, USA.

出版信息

J Cell Sci. 2019 Apr 4;132(7):jcs223826. doi: 10.1242/jcs.223826.

DOI:10.1242/jcs.223826
PMID:30948431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6467487/
Abstract

Survivin (also known as BIRC5) is an evolutionarily conserved eukaryotic protein that is essential for cell division and can inhibit cell death. Normally it is only expressed in actively proliferating cells, but is upregulated in most, if not all cancers; consequently, it has received significant attention as a potential oncotherapeutic target. In this Cell Science at a Glance article and accompanying poster, we summarise our knowledge of survivin 21 years on from its initial discovery. We describe the structure, expression and function of survivin, highlight its interactome and conclude by describing anti-survivin strategies being trialled.

摘要

存活素(也称为 BIRC5)是一种进化上保守的真核蛋白,对细胞分裂至关重要,并能抑制细胞死亡。通常情况下,它仅在活跃增殖的细胞中表达,但在大多数(如果不是全部)癌症中都上调;因此,它作为一种潜在的肿瘤治疗靶点受到了广泛关注。在这篇《细胞科学一瞥》文章及其配套海报中,我们总结了存活素自最初发现以来 21 年的研究进展。我们描述了存活素的结构、表达和功能,突出了其相互作用组,并在最后描述了正在试验的抗存活素策略。

相似文献

1
Survivin at a glance.Survivin 一览。
J Cell Sci. 2019 Apr 4;132(7):jcs223826. doi: 10.1242/jcs.223826.
2
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy.纳米颗粒介导体抑制生存素以克服癌症治疗中的耐药性。
J Control Release. 2016 Oct 28;240:454-464. doi: 10.1016/j.jconrel.2016.04.018. Epub 2016 Apr 16.
3
Treat cancers by targeting survivin: just a dream or future reality?通过靶向存活素治疗癌症:只是一个梦想还是未来的现实?
Cancer Treat Rev. 2013 Nov;39(7):802-11. doi: 10.1016/j.ctrv.2013.02.002. Epub 2013 Feb 28.
4
An Old Flame Never Dies: Survivin in Cancer and Cellular Senescence.旧情永不灭:存活素在癌症与细胞衰老中的作用
Gerontology. 2016;62(2):173-81. doi: 10.1159/000432398. Epub 2015 Jul 3.
5
Survivin: a protein with dual roles in mitosis and apoptosis.生存素:一种在有丝分裂和细胞凋亡中具有双重作用的蛋白质。
Int Rev Cytol. 2005;247:35-88. doi: 10.1016/S0074-7696(05)47002-3.
6
Survivin as a Potential Target for Cancer Therapy.生存素作为癌症治疗的潜在靶点。
Asian Pac J Cancer Prev. 2015;16(15):6187-91. doi: 10.7314/apjcp.2015.16.15.6187.
7
Potential Involvement of in Maintaining Pluripotency and Cell Differentiation of Human Stem Cells.在维持人类干细胞的多能性和细胞分化中的潜在作用。
Oxid Med Cell Longev. 2019 Jan 10;2019:8727925. doi: 10.1155/2019/8727925. eCollection 2019.
8
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?以生存素 BIRC5 为靶点的癌症治疗学:在研究了二十多年之后,我们还能做些什么?
J Exp Clin Cancer Res. 2019 Aug 22;38(1):368. doi: 10.1186/s13046-019-1362-1.
9
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.存活素:有丝分裂和细胞凋亡的关键调节因子及癌症治疗的新靶点。
Clin Cancer Res. 2008 Aug 15;14(16):5000-5. doi: 10.1158/1078-0432.CCR-08-0746.
10
Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics.**新兴的** **Survivin** **在干细胞和癌症中的重要性:新癌症治疗方法的发展**。
Stem Cell Rev Rep. 2020 Oct;16(5):828-852. doi: 10.1007/s12015-020-09995-4.

引用本文的文献

1
Expressions of apoptotic protein and gene following sulfur mustard-induced acute pulmonary injuries in rats.硫芥诱导大鼠急性肺损伤后凋亡蛋白和基因的表达
Iran J Basic Med Sci. 2025;28(10):1372-1380. doi: 10.22038/ijbms.2025.86449.18678.
2
Targeting and Suppression of Survivin in Cancer Cells Based on the Interaction of Cell Surface Vimentin with ‑Acetylglucosamine-Bearing Polymers.基于细胞表面波形蛋白与含N-乙酰葡糖胺聚合物的相互作用对癌细胞中生存素的靶向作用及抑制
ACS Omega. 2025 Aug 13;10(33):37162-37175. doi: 10.1021/acsomega.5c02098. eCollection 2025 Aug 26.
3
Immunotherapy in Glioblastoma.胶质母细胞瘤中的免疫疗法。
Cancer Treat Res. 2025;129:103-118. doi: 10.1007/978-3-031-97242-3_6.
4
Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer.靶向生存素的肽抑制剂的计算与实验发现及其在癌症治疗中的潜力
Sci Rep. 2025 Aug 20;15(1):30599. doi: 10.1038/s41598-025-13110-3.
5
Survivin can alter mitochondrial architecture by regulating phosphatidylethanolamine synthesis.存活素可通过调节磷脂酰乙醇胺的合成来改变线粒体结构。
J Cell Sci. 2025 Aug 1;138(15). doi: 10.1242/jcs.263689. Epub 2025 Aug 4.
6
Isoliensinine Induces Ferroptosis in Urothelial Carcinoma Cells via the PI3K/AKT/HIF-1α Axis: Molecular Evidence from Next-Generation Sequencing.异莲心碱通过PI3K/AKT/HIF-1α轴诱导膀胱癌细胞铁死亡:来自下一代测序的分子证据
Pharmaceuticals (Basel). 2025 Jul 6;18(7):1008. doi: 10.3390/ph18071008.
7
Genetic Variants in (rs8073069, rs17878467, and rs9904341) Are Associated with Susceptibility in Mexican Patients with Breast Cancer: Clinical Associations and Their Analysis In Silico.(rs8073069、rs17878467和rs9904341)基因变异与墨西哥乳腺癌患者的易感性相关:临床关联及其计算机模拟分析
Genes (Basel). 2025 Jun 30;16(7):786. doi: 10.3390/genes16070786.
8
Carboxylic Acid Bioisosteres Boost Nurr1 Agonist Selectivity.羧酸生物电子等排体提高Nurr1激动剂的选择性。
J Med Chem. 2025 Jul 17. doi: 10.1021/acs.jmedchem.5c01140.
9
Machine learning modeling and analysis of prognostic hub genes in cervical adenocarcinoma: a multi target therapy for enhancement in immunosurveillance.宫颈腺癌预后关键基因的机器学习建模与分析:增强免疫监视的多靶点治疗
Discov Oncol. 2025 Jul 13;16(1):1326. doi: 10.1007/s12672-025-02834-3.
10
BIRC5 as a master regulator in HCC: unraveling its role in tumor survival and therapeutic potential.BIRC5作为肝癌的主要调节因子:揭示其在肿瘤存活中的作用及治疗潜力。
Funct Integr Genomics. 2025 Jun 5;25(1):120. doi: 10.1007/s10142-025-01615-z.

本文引用的文献

1
Recent advances in understanding inhibitor of apoptosis proteins.凋亡抑制蛋白研究的最新进展
F1000Res. 2018 Dec 3;7. doi: 10.12688/f1000research.16439.1. eCollection 2018.
2
Survivin inhibits excessive autophagy in cancer cells but does so independently of its interaction with LC3.存活素抑制癌细胞中的过度自噬,但这种抑制作用与其与微管相关蛋白轻链3(LC3)的相互作用无关。
Biol Open. 2018 Oct 22;7(10):bio037374. doi: 10.1242/bio.037374.
3
Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.细胞因子网络和生存肽特异性细胞免疫应答可预测多形性胶质母细胞瘤患者的生存改善。
EBioMedicine. 2018 Jul;33:49-56. doi: 10.1016/j.ebiom.2018.06.014. Epub 2018 Jun 29.
4
Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth .Survivin 单克隆抗体可检测 Survivin 细胞表面表达并抑制肿瘤生长。
Clin Cancer Res. 2018 Jun 1;24(11):2642-2652. doi: 10.1158/1078-0432.CCR-17-2778. Epub 2018 Mar 14.
5
Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination.生存素疫苗接种后恶性胶质瘤患者循环中的CD9+/GFAP+/survivin+外泌体
Oncotarget. 2017 Oct 10;8(70):114722-114735. doi: 10.18632/oncotarget.21773. eCollection 2017 Dec 29.
6
Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.通过环境响应性树枝状介孔硅纳米粒子共递送阿霉素和 Survivin shRNA 表达质粒用于协同癌症治疗。
Pharm Res. 2017 Dec;34(12):2829-2841. doi: 10.1007/s11095-017-2264-6. Epub 2017 Sep 25.
7
Correlation between E-cadherin interactions, survivin expression, and apoptosis in MDCK and ts-Src MDCK cell culture models.MDCK和ts-Src MDCK细胞培养模型中E-钙黏蛋白相互作用、生存素表达与细胞凋亡之间的相关性
Lab Invest. 2017 Dec;97(12):1453-1470. doi: 10.1038/labinvest.2017.89. Epub 2017 Sep 11.
8
Drugging the 'undruggable' cancer targets.针对“不可成药”的癌症靶点研发药物。
Nat Rev Cancer. 2017 Aug;17(8):502-508. doi: 10.1038/nrc.2017.36. Epub 2017 Jun 23.
9
Survivin is a guardian of the intestinal stem cell niche and its expression is regulated by TGF-β.存活素是肠道干细胞龛的守护者,其表达受转化生长因子-β调控。
Cell Cycle. 2016 Nov;15(21):2875-2881. doi: 10.1080/15384101.2016.1231286. Epub 2016 Oct 7.
10
A new survivin tracer tracks, delocalizes and captures endogenous survivin at different subcellular locations and in distinct organelles.一种新型生存素示踪剂可在不同亚细胞位置和不同细胞器中追踪、使内源性生存素移位并捕获内源性生存素。
Sci Rep. 2016 Aug 12;6:31177. doi: 10.1038/srep31177.